Femasys (FEMY) has a profit margin of -511.77%, below the Healthcare sector average of 13.76%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Femasys (FEMY) currently reports a profit margin of -511.77% as of June 2026. That compares with -1011.39% in the prior-year period — up 49.4% year over year. That is below the Healthcare sector average of 13.76%. Use the charts on this page to explore Femasys's profit margin history and peer comparisons.
Femasys's profit margin increased from -1011.39% to -511.77% — a 49.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Femasys's profit margin of -511.77% is lower than the Healthcare sector average of 13.76%. That is roughly 3819.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Femasys's current -511.77% should be judged against Healthcare norms (sector average: 13.76%) and against FEMY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -511.77%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for Femasys, and consider following FEMY for alerts when major investors trade the stock.